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Abstract
Background: Corticosteroid injections can be performed blind (landmark-guided) or with image guidance, and this
may account for variable clinical outcomes. The objective of this study was to assess the effectiveness and safety of
image-guided versus blind corticosteroid injections in improving pain and function among adults with shoulder
pain.
Methods: MEDLINE, the Cochrane Controlled Trials Register and EMBASE were searched to May 2010. Additional
studies were identified by searching bibliographies of shortlisted articles. Search items included blind, landmark,
anatomical, clinical exam, image-guided, ultrasound, fluoroscopy, steroid injection, frozen shoulder, random
allocation, randomized controlled trial (RCT) and clinical trial.
Randomized controlled studies comparing image-guided versus blind (landmark-guided) corticosteroid shoulder
injections that examined pain, function and/or adverse events were included. Independent extraction was done by
two authors using a form with pre-specified data fields, including risk of bias appraisal. Conflicts were resolved by
discussion. The decision to pool data was based on assessment of clinical design homogeneity. When warranted,
studies were pooled under a random-effects model.
Results: Two RCTs for pain, function and adverse events (n = 101) met eligibility criteria. No serious threats to
validity were found. Both trials compared ultrasound-guided versus landmark-guided injections and were judged
similar in clinical design. Low to moderate heterogeneity was observed: shoulder pain I
2 = 60%, function I
2 = 22%.
A meta-analysis demonstrated greater improvement with ultrasound-guided injections at 6 weeks after injection in
both pain (mean difference = 2.23 [95% CI: 1.27, 3.18]), as assessed with a 0 to 10 visual analogue scale, and
shoulder function (standardised mean difference = 1.09 [95% CI: 0.61, 1.57]) as assessed with shoulder function
scores. Although more adverse events (all mild) were reported with landmark-guided injections, the difference was
not statistically significant (risk ratio = 0.20 [95% CI: 0.04, 1.13]).
This review was only based on two moderate-sized trials. Blinding of patients was not performed in both trials,
causing some risk of bias in outcome assessment since primary endpoints were wholly or partially patient-reported.
Conclusion: There is a paucity of RCTs on image-guided versus landmark-guided corticosteroid shoulder injections
examining pain, function and adverse events. In this review, patients who underwent image-guided (ultrasound)
injections had statistically significant greater improvement in shoulder pain and function at 6 weeks after injection.
Image-guided (ultrasound) corticosteroid injections potentially offer a significantly greater clinical improvement
over blind (landmark-guided) injections in adults with shoulder pain. However, this apparent benefit requires
confirmation from further studies (adequately-powered and well-executed RCTs).
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Shoulder pain is common in the general population.
Corticosteroid injections are widely used to treat
shoulder pain irrespective of the underlying aetiology (e.
g. rotator cuff disease, bursitis, adhesive capsulitis, etc.).
The injections can be performed “blind” (via anatomical
landmarks to guide placement of the needle) or with
image guidance (usually ultrasound with visualisation of
the needle tip at the target site) [1,2]. Studies have
demonstrated that needle placement is more accurate
with image guidance [3]. However, it is more controver-
sial whether accuracy of needle placement has a signifi-
cant impact on clinical outcome. Some studies have
demonstrated improvement in shoulder symptoms irre-
spective of whether the needle was in the targeted struc-
ture or not [4]. Others have reported improved clinical
outcome with image-guided injections [3].
These conflicting results may have come about from
different study designs. A systematic review assessing
whether there is a significant difference in clinical out-
come between blind (landmark-guided) and image-
guided injections is required to assess the best-available
evidence.
Objective
To assess the effectiveness and safety of image-guided
versus blind (landmark-guided) corticosteroid injections
in adults with shoulder pain. Outcome measures for
effectiveness included change in pain and function
scores. Safety was assessed by documentation of adverse
effects.
Methods
Eligibility criteria
We considered randomized controlled trials of image-
guided versus blind (landmark-guided) corticosteroid
shoulder injections in adults 18 years and above with
shoulder pain due to soft tissue disorders. Specific
exclusions were shoulder pain due to osseous pathology
(e.g. osteoarthritis, osteonecrosis), duration of shoulder
pain less than three weeks, inflammatory joint disease,
previous trauma in the shoulder region, previous phy-
siotherapy and previous local steroid injection. Only sin-
gle corticosteroid injections over time were included.
Anatomical target sites included the glenohumeral joint,
the subacromial space and specific tendon sheaths. All
corticosteroid preparations of various volumes and types
were included. All image-guided techniques were con-
sidered including ultrasound and fluoroscopy. The pri-
mary outcome measures were pain as assessed by the
visual analogue scale (VAS) and shoulder function by
any validated scale such as the Constant Score. Safety, a
secondary outcome, was evaluated by the frequency of
adverse events. Effectiveness was assessed by the change
in pain and function scores evaluated at baseline and
the final assessment period.
Information Sources and Search
Studies were identified by searching electronic databases
and the bibliographies of shortlisted articles. MEDLINE,
the Cochrane Controlled Trials Register and EMBASE
were searched in all languages to May 2010. A limited
update literature search was made from 30 May 2010 to
14 March 2011. Key search terms were blind, landmark,
anatomical, clinical exam, image-guided, ultrasound,
fluoroscopy, steroid injection, frozen shoulder, random
allocation, r a n d o m i z e dc o n t r o l l e dt r i a l( R C T )and clini-
cal trial.
Study selection
Three authors (ES, WL, and DB) assessed the titles and
abstracts from the electronic search for eligibility. The
full-text article of shortlisted studies were then retrieved
and further assessed. All review authors decided on
study inclusion.
Data collection process
Two authors (DB, WL) independently extracted charac-
teristics of included studies using a form with pre-speci-
fic data fields. The following characteristics were sought:
study design, participants (eligibility criteria) and setting,
interventions (type of injection, corticosteroid prepara-
tion, person delivering the injection), length of follow-
up, assessment periods, and outcomes. Primary study
authors were contacted by email for additional details
when required.
Risk of bias appraisal
The same authors (DB, WL) also appraised studies inde-
pendently for internal validity by examining sequence
generation, allocation concealment (both at the study
level), blinding of patients, investigators and outcome
assessors, incomplete data reporting, selective outcome
reporting (all at the outcome level) and other biases fol-
lowing Cochrane review methods for interventions. Dif-
ferences were resolved by referring to the original article
and/or by discussion with a third party (ES). Only trials
with low or unclear risk of bias in sequence generation
and allocation concealment were included in the meta-
analyses. Data were entered and analyzed in the Revman
Review Manager V5 software [5].
Summary measures
For pain and shoulder function scores, treatment effects
were summarized by the mean difference (MD) and
standardized mean difference (SMD) respectively. For
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risk ratio (RR) was used.
Synthesis of results
Heterogeneity in clinical design was ascertained by
examination of the table of characteristics of included
studies. Statistical heterogeneity was quantified using the
I
2 statistic and the chi-square-based test. When war-
ranted, pooling was made under a random effects
model, in view of anticipated differences in clinical
design [6].
Results
The search yielded nine potential studies (Figure 1), of
which two satisfied inclusion criteria [7,8]. The seven
excluded studies are listed in references [9-15]. Detailed
patient characteristics and aspects of clinical design of
the two included studies are provided in Additional File
1. The two trials were similar in clinical design (total
patients = 101, image-guided = 51 and landmark-guided
= 50). Both compared ultrasound-guided versus land-
mark-guided injections. With only two studies available,
estimates of statistical heterogeneity were deemed
imprecise. The estimated proportion of between-study
variability (I
2) was 61% for shoulder pain and 22% for
shoulder function. Based on the chi-square test, no sig-
nificant statistical heterogeneity was found in all out-
comes but this is likely due to low statistical power.
Shoulder function was assessed by the Constant score
or the Shoulder Function Assessment scale. Shoulder
pain was assessed by VAS. Risk of bias assessments are
outlined in Figure 2. Patients were not blinded to the
injection technique and this may have resulted in some
bias particularly for purely subjective assessments such
as VAS (a self-assessment scale). The risk of bias for
shoulder function assessment in terms of blinding was
judged to be of low risk in both studies. Some risk of
bias assessments were judged unclear as no specific
details in the studies could be obtained from the study
authors for the relevant assessment. No serious threats
to validity were found.
Using a random effects model, pooling of data from
both trials demonstrated statistically significant greater
improvement with ultrasound-guided injections at 6
weeks after injection in both pain (mean difference =
2.23 [95% CI: 1.27, 3.18]), as assessed with a 0 to 10
visual analogue scale, and shoulder function (standar-
dised mean difference = 1.09 [95% CI: 0.61, 1.57]) as
 
# of records identified through 
database searching = 128 
(Pubmed, EMBASE and the 
Cochrane Library) 
Number of records after duplicates removed = 128 
# of records identified through 
other sources = 5 
(bibliography of shortlisted articles, 
web-search in Google) 
# of records screened on the 
basis of title and abstract = 128 
# of full-text articles assessed 
for eligibility = 9 
# of studies included = 2  
# of full-text articles excluded = 7  
      Reasons:    
      Study design-ineligible =1 
        Intervention-ineligible =2 
        Comparison-ineligible = 1 
        Outcome-ineligible=3 
# of records excluded = 119 
Figure 1 Flow diagram of study selection.
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More adverse effects (all mild) were also reported with
blind injections though the difference was not statisti-
cally significant (risk ratio = 0.20 [95% CI: 0.04, 1.13];
Figure 5). Adverse events included slight increase in
pain and skin peeling post-injection.
Discussion
Corticosteroid injections are commonly used to treat
shoulder pain although studies assessing the efficacy of
such injections have given conflicting results [16,17]. Con-
clusions of systematic reviews have been limited by small
sample sizes and variable methodological quality and het-
erogeneity. This current review sought to assess the effec-
tiveness and safety of image-guided versus blind
corticosteroid injections. To our knowledge, such a review
has not been published before. Patients who underwent
image-guided (ultrasound) injections had statistically sig-
nificant greater improvement in shoulder pain and func-
tion at 6 weeks after injection, and also had less adverse
events. These findings would suggest that ultrasound-
guided corticosteroid injections are more beneficial than
blind injections. The results should be interpreted with
some caution due to the limited number of studies and
small sample sizes of the two included studies.
Any beneficial effect of steroid injections is likely due
to its anti-inflammatory effect. Inaccurate placement of
steroid may result in a partial response due to further
diffusion of steroid away from its target site. Henkus et
al. reported that 62.5 to 76% of subacromial injections
were accurately placed when given blind, the intended
target being the subacromial bursa. Injections isolated to
the subacromial bursa resulted in significantly decreased
pain and improved functional scores, whereas injection
of other structures resulted in increased pain scores
[18]. Eustace et al. reported 29% (4 out of 14) of suba-
cromial and 42% (10 out of 24) of glenohumeral joint
injections were accurately placed when given blind.
There was also a positive correlation between clinical
outcome and accurately placed injections [19].
Ultrasound is a safe and accurate technique for guid-
ing aspiration and infiltration that ensures correct place-
ment of the needle and delivery of the drug.
Ultrasound-guided injections allow direct visualisation
of the needle in real-time as it pierces the skin to enter-
ing the target site. Ultrasound scanning can also be per-
formed immediately after injections to visualise the
location of the steroid deposit which appears as echo-
genic foci or lines, with or without acoustic shadowing
[20]. Imaging in general (including ultrasound) requires
more resources (skilled manpower, imaging equipment,
etc.), and at our institution, imposes a higher financial
expense to the patient. However, appropriate use of
imaging is better answered with a cost-effectiveness
study to assess whether significant healthcare savings
can be achieved overall.
One limitation of the reviewed studies is that the par-
ticipants were not blinded for treatment group and this
m a yh a v er e s u l t e di ns o m eb i a sf a v o u r i n gu l t r a s o u n d -
guided injections, particularly with self-reporting assess-
ments. However, successful blinding of participants to
fulfil a double-blind study is difficult to achieve in prac-
tice. Another limitation is the small number of high-
quality studies available for review and the small sample
sizes in the available studies. In addition, ultrasound-
guided injections in the included studies were performed
Figure 2 Risk of bias assessments (Cochrane Collaboration) of
included studies. + indicates a low risk of bias; - indicates a high
risk of bias;? indicates an unclear risk of bias.
Figure 3 Forest plot of shoulder pain (VAS).
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a significant difference if the image-guided injections
were performed by radiologists, who arguably do more
image-guided injections than other healthcare profes-
sionals, certainly at least in our institution. We would
like to see more studies comparing blind versus image-
guided injections, including the former performed by
experienced clinicians and the latter performed by
experienced radiologists.
Conclusion
Image-guided (ultrasound) corticosteroid injections
potentially offer a significantly greater clinical improve-
ment over blind injections in adults with shoulder pain.
The results should be interpreted with some caution
due to the limited number of studies and small sample
sizes available for review. More adequately-powered and
well-executed RCTs are required.
Additional material
Additional files 1: Characteristics of included studies. Detailed patient
characteristics and aspects of clinical design of the two included studies.
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